CONCLUSIONS : The variants of the ITPA gene , which could protect against haemolytic anaemia and RBV dose reduction , were associated with a high rate of SVR by standard PEG-IFN and RBV therapy in a subset of Japanese patients with the favourable TT genotype at rs8099917 of IL28B .